Literature DB >> 31392068

IgG4-Related Ophthalmic Disease Presenting as Meningitis and Panuveitis.

Maria A Mavrommatis1, Sarah A Avila1,2, Richard France1,2.   

Abstract

PURPOSE: We report an uncommon case of immunoglobulin gamma 4-related ophthalmic disease (IgG4-ROD) presenting as meningitis and panuveitis. OBSERVATIONS: A 35-year-old male with no prior ophthalmic history presented with headaches, altered mental status, and fever of unknown origin. A lumbar puncture (LP) revealed an elevated white count with lymphocytic predominance, confirming a suspected meningitis. After an extensive work-up, he was discharged on oral acyclovir to cover for presumed aseptic meningitis. The patient initially improved, however, bilateral eye pain, redness, and photophobia 2 weeks after discharge prompted his first visit to the ophthalmology clinic. Exam at that time was consistent with bilateral anterior uveitis for which he was given topical prednisolone and cyclopentolate. In addition to the preceding work-up, quantitative immunoglobulin serology including IgG4 levels was added. At follow-up, he was found to have increased ocular inflammation with vitreitis, nerve head edema, and subclinical macular thickening. Visual acuity (VA) had decreased in both eyes. Serology titers for IgG had resulted in a significant elevation in IgG subclass 4 (IgG4). Optical coherence tomography (OCT) and fundus fluorescein angiography (FFA) confirmed posterior retinal involvement. The patient was diagnosed with presumed bilateral panuveitis secondary to IgG4-ROD. CONCLUSIONS AND IMPORTANCE: IgG4-RD can be a serious condition that requires careful consideration and intuition to diagnose. This report serves to encourage ophthalmologists to consider IgG4-ROD in cases of idiopathic systemic inflammation with ophthalmic involvement.

Entities:  

Year:  2019        PMID: 31392068      PMCID: PMC6662508          DOI: 10.1155/2019/5653282

Source DB:  PubMed          Journal:  Case Rep Ophthalmol Med


  7 in total

1.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Tadashi Yoshino; Shigeo Nakamura; Shigeyuki Kawa; Hideaki Hamano; Terumi Kamisawa; Toru Shimosegawa; Akira Shimatsu; Seiji Nakamura; Tetsuhide Ito; Kenji Notohara; Takayuki Sumida; Yoshiya Tanaka; Tsuneyo Mimori; Tsutomu Chiba; Michiaki Mishima; Toshifumi Hibi; Hirohito Tsubouchi; Kazuo Inui; Hirotaka Ohara
Journal:  Mod Rheumatol       Date:  2012-01-05       Impact factor: 3.023

Review 2.  IgG4-related disease.

Authors:  John H Stone; Yoh Zen; Vikram Deshpande
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

Review 3.  Diagnostic criteria for IgG4-related ophthalmic disease.

Authors:  Hiroshi Goto; Masayuki Takahira; Masahiro Takahira; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 5.  IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review.

Authors:  Albert Wu; Nicholas H Andrew; Alan A McNab; Dinesh Selva
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

Review 6.  Immunoglobulin G4-related ophthalmic disease.

Authors:  Wei-Kuang Yu; Chieh-Chih Tsai; Shu-Ching Kao; Catherine Jui-Ling Liu
Journal:  Taiwan J Ophthalmol       Date:  2018 Jan-Mar

7.  Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease.

Authors:  Kuang-Hui Yu; Tien-Ming Chan; Ping-Han Tsai; Ching-Hui Chen; Pi-Yueh Chang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  7 in total
  1 in total

1.  IgG4-related hypertensive granulomatous anterior uveitis.

Authors:  Judy L Chen; Mauranda Men; Bita V Naini; Edmund Tsui
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.